Bio-Connect

anti-Sirtuin 2 (human), mAb (S2R233-1)

Research Use Only
AG-20A-0076
AdipoGen Life Sciences
ApplicationsWestern Blot, ELISA
Product group Antibodies
ReactivityHuman
TargetSIRT2
Price on request
Packing Size
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    AdipoGen Life Sciences
  • Product Name
    anti-Sirtuin 2 (human), mAb (S2R233-1)
  • Delivery Days Customer
    10
  • Applications
    Western Blot, ELISA
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    S2R233-1
  • Concentration
    1 mg/ml
  • Gene ID22933
  • Target name
    SIRT2
  • Target description
    sirtuin 2
  • Target synonyms
    NAD-dependent deacetylase sirtuin-2; NAD-dependent protein deacetylase sirtuin-2; regulatory protein SIR2 homolog 2; silent information regulator 2; SIR2; SIR2L; SIR2L2; SIR2-like protein 2; sir2-related protein type 2; sirtuin type 2
  • Host
    Mouse
  • Isotype
    IgG2b
  • Scientific Description
    Monoclonal Antibody. Recognizes human sirtuin 2. Detects a band of ~45kDa by Western blot. Isotype: Mouse IgG2bkappa. Clone: S2R233-1. Applications: ELISA, WB. Liquid. 0.2microm-filtered solution in PBS, pH 7.4. Contains no preservatives. Sirtuin-2 is a NAD-dependent protein deacetylase, which deacetylates the Lys-40 of a-tubulin. It is involved in the control of mitotic exit in the cell cycle. Furthermore, a variety of age-associated diseases such as type 2 diabetes, obesity, osteoporosis, and Alzheimers disease are associated with sirtuins. Selective inhibition of Sirtuin-2 achieves neuroprotection and identifies Sirtuin-2 to be a potential therapeutic avenue in Huntingtons and Parkinsons disease. - Sirtuin-2 is a NAD-dependent protein deacetylase, which deacetylates the Lys-40 of a-tubulin. It is involved in the control of mitotic exit in the cell cycle. Furthermore, a variety of age-associated diseases such as type 2 diabetes, obesity, osteoporosis, and Alzheimers disease are associated with sirtuins. Selective inhibition of Sirtuin-2 achieves neuroprotection and identifies Sirtuin-2 to be a potential therapeutic avenue in Huntingtons and Parkinsons disease.
  • Reactivity
    Human
  • Storage Instruction
    2°C to 8°C,-20°C
  • UNSPSC
    12352203